同期放化疗治疗中晚期鼻咽癌的疗效观察_临床医学论文.docVIP

同期放化疗治疗中晚期鼻咽癌的疗效观察_临床医学论文.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
同期放化疗治疗中晚期鼻咽癌的疗效观察_临床医学论文.doc

同期放化疗治疗中晚期鼻咽癌的疗效观察_临床医学论文 同期放化疗治疗中晚期鼻咽癌的疗效观察_临床医学论文 作者:蓝玉宏 马慧敏 杨清绪【摘要】 目的 观察同期放化疗治疗中晚期鼻咽癌的疗效。方法 100例确诊为中晚期鼻咽癌患者随机分为同期放化疗组(A组)50例和单纯放疗组(B组)50例,A组在放射治疗的第1、4周给予2个周期顺铂加5氟尿嘧啶方案化疗;B组只给单纯放射治疗。结果 A组完全缓解率84.0%(42/50)高于B组64.0%(32/50)(χ2=4.18,0.05);A组1、3年生存率分别为94.0%(47/50)、72.0%(36/50),高于B组88.0%(44/50)、54.0%(27/50)(χ2=0.80,Pgt;0.05,χ2=4.75,0.05);A组局部复发率8.0%(4/50)明显低于B组26.0%(13/50)(χ2=3.85,0.05);A组3年远处转移率分别为14.0%(7/50)明显低于B组32.0%(16/50)(χ2=4.12,0.05)。A组黏膜损伤54.0%(27/50)明显高于B组29.4%(10/50)(χ2=4.38,0.05)。结论 同期放化疗可以降低远处转移和提高3年生存率,其毒性反应可以耐受,值得在临床中推广。   【关键词】鼻咽癌;晚期放疗;放化疗       【Abstract】 Objective To evaluate the curative effect of radiotherapy combined with concurrent chemotherapy for the treatment of advanced nasopharyngeal carcinoma.Methods 100 cases with advanced nasopharyngeal carcinoma(stage III and IVa)were randomized into 2 groups.Group A received radiotherapy with concurrent chemotherapy(n=50)and Group B received radiotherapy alone(n=50).A group of radia-tion therapy in the 1,4 weeks to give 2 cycles of cisplatin plus 5-fluorouracil chemotherapy;B group only to radiation therapy alone.Results The rate of complete remission were 84.0%(42/50)in A grouphigher than the 64.0%(32/50)in B group(χ2=4.18,0.05);The rates of 1,3-year survival were 94.0%(47/50),72.0%(36/50)in A group higher than the 88.0%(44/50), 54.0%(27/50)in B group(χ2=0.80,χ2=2.75, 0.05); The rate of local recurrence were 8.0 percent(4/50)in A group were significantly lower than 26.0%(13/50)in B group(χ2=3.85,0.05);The rate of distant metastasis of 3-year were 14.0%(7/50)in A Group were significantly lower than 32.0%(16/50)in B Group(χ2=4.12,0.05);the mucosal injury were 54.0%(27/50)in A group were significantly higher than 29.4%(10/50)in B group(χ2=4.38,0.05).Conclusion Radiotherapy with concurrent chemotherapy can improve the 3-year survival rate and decrease the distant metastasis rate in patients with advanced nasopharyngeal carcinoma.   【Key words】Nasopharyngeal carcinoma; Advanced;Radiotherapy;Chemoradiother

您可能关注的文档

文档评论(0)

619731806 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档